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Abstract
Purpose—We performed an exploratory analysis of data from the National Spina Bifida Patient 
Registry (NSBPR) to assess variation in the frequency of bladder reconstruction surgeries among 
NSBPR centers.
Methods—We queried the 2009–2014 NSBPR to identify patients who had ever undergone 
bladder reconstruction surgeries. We evaluated demographic characteristics, SB type, functional 
level, mobility, and NSBPR center to determine whether any of these factors were associated with 
reconstructive surgery rates. Multivariable logistic regression was used to simultaneously adjust 
for the impact of these factors.
Results—We identified 5,528 patients with SB enrolled in the NSBPR. Of these, 1,129 (20.4%) 
underwent bladder reconstruction (703 augmentation, 382 continent catheterizable channel, 189 
bladder outlet procedure). Surgery patients were more likely to be older, female, non-Hispanic 
white, higher lesion level, myelomeningocele diagnosis, non-ambulators (all p<0.001) and non-
privately insured (p=0.018). Bladder reconstruction surgery rates varied among NSBPR centers 
(range 12.1–37.9%, p<0.001). After correcting for known confounders, NSBPR center, SB type, 
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mobility, gender and age (all p<0.001) were significant predictors of surgical intervention. Race 
(p=0.19) and insurance status (p=0.11) were not associated with surgical intervention.
Conclusions—There is significant variation in rates of bladder reconstruction surgery among 
NSBPR centers. In addition to clinical factors such as mobility status, lesion type, and lesion level, 
non-clinical factors such as patient age, gender and treating center are also associated with the 
likelihood of an individual undergoing bladder reconstruction.
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INTRODUCTION
Spina bifida (SB) is the most common permanently disabling birth defect in the US.1, 2 
Neurogenic bladder dysfunction is the norm in SB and is a major source of morbidity.3, 4 In 
order to treat or avert these concerns, many individuals with SB undergo bladder 
reconstruction surgeries such as bladder augmentation.
Previous research has noted significant variation in the use of bladder augmentation in 
children with spina bifida.5 The reasons behind this variation are not clear. A recent study 
revealed that patients with private insurance were more likely to undergo augmentation (as 
compared to incontinent urinary diversion) than were publicly insured patients.6
A high degree of variation in the surgical management of SB patients is concerning because 
such variation suggests either 1) the lack of a clear, widely accepted standard of care for the 
use of these surgical procedures, or 2) that surgeons do not uniformly adhere to that 
standard. Further, such variation implies either overuse or underuse of those procedures, 
either of which may be significant problems in these complex patients. Overuse of bladder 
reconstruction procedures is of concern due to the significant potential morbidity and 
expense of surgery; underuse is problematic as well, as incontinence can have a detrimental 
impact on patients’ quality of life.7, 8 The objective of this study was to describe current 
patterns of care among NSBPR centers regarding bladder reconstruction, including the 
patient characteristics that are associated with likelihood of surgery. Our exploratory, 
secondary aim was to evaluate variation in surgical patterns, with adjustment for possible 
differences in case mix. We hypothesized that significant variation exists among NSBPR 
clinics in the use of bladder reconstruction procedures.
PATIENTS AND METHODS
Data Source
The NSBPR was established following a 2005 survey of SB centers across the US by the 
Spina Bifida Association and the US Centers for Disease Control and Prevention (CDC). 
The goals of the NSBPR are to describe the SB clinic population and documenting care 
patterns across centers in the U.S. in order to improve the consistency and quality of care 
and provide an infrastructure to support SB clinical research. In 2009, the NSBPR began 
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accruing patients at 10 clinics; in 2011, enrollment was expanded to 19 clinics. As of 
December 2014, the NSBPR had enrolled 5,596 SB patients from 23 clinics.
Clinics with small enrollment (< 30 patients) were excluded, leaving a total of 5,528 patients 
from 19 clinics for this analysis. After institutional review board approval and obtaining 
informed consent/assent from parents and patients, participating clinics collected 
longitudinal data on individuals with SB.9, 10 Limited data were also collected on patients 
who were Eligible but Not Enrolled (ENE) in the NSBPR to evaluate for possible selection 
bias (see below). At the initial visit, basic demographic/diagnostic information in addition to 
previous surgical procedures were collected from each patient. At the initial visit and each 
subsequent annual visit, information on insurance status, education, and employment were 
collected in addition to any interval procedures, treatments, and outcomes.
Statistical Analysis
Predictor variables were a priori selected based on biologic plausibility and/or demonstrated 
associations in the literature. Covariates included basic patient demographics and clinical 
variables captured in the NSBPR: age, gender, race/ethnicity (non-Hispanic white, non-
Hispanic black, Hispanic or Latino, or other/refused/unknown), insurance payer (any private 
vs. non-private), SB type (myelomeningocele vs. non-myelomeningocele), functional level 
of SB lesion (thoracic, lumbar, or sacral), mobility status (community ambulator, household 
ambulator, non-functional ambulator, non-ambulator, or not applicable due to age if <2 
years), and treating SB center.11
We performed bivariate tests of association between these predictor variables and our 
primary outcome of interest, i.e., whether a particular patient underwent a bladder 
reconstruction surgery. A composite “any surgery” outcome was first examined, and then 
individual surgeries were examined as sensitivity analyses. The specific bladder 
reconstruction surgeries were bladder augmentation, creation of a continent catheterizable 
channel (e.g., Mitrofanoff procedure), bladder outlet procedure, or vesicostomy creation/
closure. We performed multivariable logistic regression to adjust for confounding among the 
above covariates and outcomes. Level of lesion was insignificant in the full model and thus 
was excluded; all other predicters listed above were included in the final model. A two-sided 
alpha of 0.05 and 95% confidence intervals (CI) were used to define statistical significance. 
All analyses were performed using SAS 9.3 or R.
Selection Bias Analysis
Because of concerns that enrollment of patients into the NBSPR by SB centers was not 
random,11 we used previously described statistical methods in an attempt to control for 
selection bias in our analysis.12, 13 We first performed logistic regression among eligible and 
enrolled (EAE) patients to determine the association between various characteristics and the 
odds of having the procedures of interest performed in that population; due to small numbers 
of predicted events at some centers, center was not included as a covariate in this model. 
Using beta coefficients from this model, we estimated predicted probability of having 
bladder surgery for each eligible and not enrolled (ENE) patient according to the known 
variables. Then, we used this probability to assign a surgery status (yes/no) to each of the 
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498 ENE patients using a Bernoulli trial. In this trial, a surgery status is generated at random 
for each patient with a probability of ‘success’ (surgery = yes) that is equal to the previously 
estimated probability of surgery. This simulation was executed 10,000 times for ENE 
patients and each execution was identified with a unique seed number. Once all ENE 
patients had been probabilistically assigned a surgery status, the datasets from ENE and 
enrolled patients were combined into one dataset for the probabilistic selection bias analysis. 
In this combined dataset, enrollment was included in the model.
Selection bias is present if surgery status differed by enrollment in the different strata of the 
predictor variables. To test for this, we separated the datasets by surgery status and used 
logistic regression to model the likelihood of enrollment for individuals in each dataset, 
adjusted for other characteristics shown to be associated with surgery in our previous 
models. From these logistic regression models, we then calculated OR by exponentiating the 
beta-coefficients and calculated a Ratio of Selection Probability Ratios (RSPR) by dividing 
the OR obtained in the surgery dataset by the OR obtained in the non-surgical dataset for 
each stratum. Our final adjusted odds ratio (AOR) was then calculated by dividing observed 
OR by RSPR.
RESULTS
Demographics
In total, we included 5,528 patients with SB (Table 1). The median age of enrolled patients 
was 11.7 years (mean 13.4 years, range 0–82 years). Most patients were female (52.7%), 
non-Hispanic whites (64.1%) with non-private insurance (52.9%). Most patients had 
myelomeningocele (MMC) form of SB (79.5%), and the lesion was most commonly present 
at the lumbar level (53.5%). The majority of patients were community ambulators (53.6%).
Bladder Reconstruction Procedures in NSBPR Patients
Among NSBPR participants, 1,129 (20.4%) underwent a bladder reconstruction procedure 
of some kind. Of these, 703 (62.3%) underwent bladder augmentation, 382 (33.8%) 
underwent creation of a continent catheterizable channel, 189 (16.7%) bladder outlet 
procedure, and 299 (26.5%) underwent vesicostomy creation or closure. Some patients 
underwent multiple procedures.
Variation in Bladder Reconstruction Procedures
On bivariate analysis (Table 1), patients undergoing bladder reconstruction surgeries were 
older than non-surgical patients (median 16.7 vs. 9.9 years, p<0.001); more likely to be 
female (22.5 v. 18.1%, OR 1.3, p<0.001); more likely to be non-ambulatory (28.4% non-
ambulators v. 15.4% community ambulators, OR 2.18, p<0.001); and more likely to have 
non-private insurance (21.7 vs. 19.0%, OR 1.17, p=0.016). Surgical patients were less likely 
to be non-Hispanic black or Latino than non-Hispanic white (OR 0.74 and 0.79, respectively, 
p<0.001); less likely to have a lumbar or sacral than thoracic lesion (OR 0.54 and 0.26, 
p<0.001); and less likely to have a non-MMC variant of SB (OR 0.32, p<0.001). 
Importantly, there was a significant range of surgical utilization among NSBPR centers 
(12.1–37.9%, OR 0.56–2.47, p<0.001). This effect remained consistent for each surgery 
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tested (vesicostomy, catheterizable channel, outlet procedure, and bladder augment) in 
addition to the composite “any surgery” outcome.
On multivariable analysis (Table 2), reduced ambulatory ability (adjusted OR (AOR) 1.71 
for non-ambulatory patients, p<0.001), female gender (AOR 1.33, p<0.001) and increased 
patient age (AOR 28.71 for 13–18 year olds compared with those younger than 2 years old, 
p<0.001) were significant predictors of bladder reconstruction surgery. Non-MMC lesion 
type was associated with lower odds of undergoing bladder reconstruction surgery (AOR 
0.47, p<0.001. Race (p=0.19) and insurance status (p=0.11) were not associated with bladder 
reconstruction surgery. Consistent with our bivariate analysis, NSBPR center remained 
significantly associated with bladder reconstruction surgeries independent of the above 
demographic, social, and condition-related factors (AOR range 0.70–3.85, p<0.001). As on 
bivariate analysis, this remained consistent for each surgery tested.
Selection Bias
After adjusting for the likelihood of being enrolled if a patient had surgery (Table 3), most 
adjusted odds ratios were similar to the original odds ratios calculated solely based on 
enrolled patient data. The two exceptions were comparisons of non-Hispanic black vs. white 
patients and private vs. non-private insurance, both of which were not significant on initial 
analysis but became significant following correction for selection bias. However, it should 
be noted that the magnitude of these changes after bias correction was small (0.62 to 0.72 
and 1.07 to 1.31, respectively; Table 3). This implies that these factors may be subject to 
statistically significant selection bias, but that the impact of this bias appears to be relatively 
limited.
DISCUSSION
In this national, multicenter study, we confirmed the presence of significant variation in the 
use of bladder reconstruction surgeries among NSBPR centers. The overall surgical rate 
across all centers was 20%. At some centers, however, only 12% of patients underwent 
bladder reconstruction procedures; at other centers, meanwhile, up to 38% of patients 
underwent bladder reconstruction procedures. To place this in context, our results indicate 
that 15 (79%) of the 19 included centers operated within +/− 2 SD of each other (Table 2); 
thus 4 centers (21%) were relative outliers in terms of surgical volume, even after adjusting 
for clinical and nonclinical variables. This effect remained similarly consistent for each 
specific type of bladder surgery as well as our main outcome of any bladder surgery.
This finding is consistent with previous publications. Wang and colleagues recently reported 
significant geographic variation in the use of bladder augmentation. Their analysis revealed 
a 6.5-fold variation in the use of bladder augmentation surgery among states, but also noted 
a slow decrease in surgical utilization across the country during the study period (1998–
2011). This surgery is often performed to protect the kidneys; as expected, the rate of 
bladder surgery was inversely correlated, both geographically and temporally, with the rate 
of renal insufficiency admissions among SB patients.14
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In addition to disease-related factors such as mobility status and lesion type and level, non-
disease-related factors such as patient age, gender, race and the center at which an individual 
is treated are also associated with the likelihood of an individual undergoing bladder surgery. 
These findings are also in keeping with previously published literature. In another analysis, 
SB patients with private insurance were significantly more likely to undergo bladder 
augmentation (as compared to incontinent urinary diversion) than were publically insured 
patients.6 As these studies highlight, the decisions to proceed with urinary reconstruction 
surgeries are complex and involve individuals’ medical condition as well as other non-
medical aspects of their care. Given the complexity of surgical decision-making in this 
population, it is perhaps unsurprising that some variation should exist among centers caring 
for individuals with SB. However, the degree of variation seen in these studies is intriguing, 
as it would seem to imply overuse or underuse of these procedures at some centers. In 
urology as in other areas of medicine, such variation has been noted to be problematic, even 
when consensus is lacking about the most appropriate choice of intervention.15–20 Our 
results suggest that the hospital at which an individual is treated is more likely to influence 
surgical decision-making than his or her race, mobility status, or lesion level. Given the 
significant social and financial costs of bladder reconstruction surgeries, this level of 
variation may not be appropriate.
The findings of our study must be interpreted in the context of study limitations. The 
NSBPR continues to undergo improvements and modifications to ensure the validity of its 
data. Whereas clear definitions are provided for the functional outcomes that we have 
analyzed, these are still potentially subject to variation in their interpretation and reporting 
by different individuals at different clinics. This raises particular caveats when attempting to 
compare outcomes among different centers. Furthermore, data regarding patient renal 
function and anatomy are being incorporated into the newer versions of NSBPR which may 
make it possible to determine if the presence of renal impairment influences rates of bladder 
reconstruction surgery. Selection bias may be a threat to external validity. NSBPR is clinic-
based, so it may not represent SB patients who do not attend SB clinics. It is also possible 
that the clinics participating in the registry are not representative of SB clinics in general; 
this possibility may have been amplified by our decision to exclude low-volume clinics from 
the analysis. No attempt was made to ensure representativeness in choosing NSBPR centers; 
indeed, the fact that all NSBPR clinics are hospital-based and multidisciplinary may limit its 
generalizability. Nevertheless, we believe that NSBPR probably characterizes the type of 
care received by patients at the majority of SB clinics in the United States. In addition, 
selection bias may be a threat to internal validity: participating clinics enrolled most, but not 
all, eligible patients, raising concerns that those who are eligible but not contributing data 
may be different from those who are. In an attempt to evaluate the possible impact of this 
bias, we conducted a rigorous analysis (including a 10,000 run simulation of enrolled and 
ENE data) based on the best available literature on this topic.12, 13 Importantly, we did not 
see a marked difference in outcomes before and after these adjustments (Table 3), implying 
that, while it may be present, selection bias is unlikely to play a clinically significant role in 
our findings.
It should also be noted that institutional variability may simply represent regional 
differences in philosophies regarding the role of surgery for individuals with SB rather than 
Routh et al. Page 6
J Urol. Author manuscript; available in PMC 2019 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
underlying biological differences; for example, the underlying reason for performing surgery 
in some regions may be continence (i.e., driven by social or quality of life concerns) as 
opposed to bladder hostility and concern for renal compromise in others (e.g., elevated 
detrusor leak point pressures, etc). The goal of this report is not to pass judgment on a 
particular site or philosophy, but rather to highlight that the probability of bladder 
reconstruction surgery in a child with SB is likely to vary between institutions, and that the 
probability of surgery varies depending on both clinical and non-clinical factors.
CONCLUSIONS
There is significant variation in bladder reconstruction surgery rates among NSBPR centers. 
In addition to disease-related factors such as mobility status, lesion type and level, non-
disease-related factors such as patient age, gender and treating center are also associated 
with the likelihood of an individual undergoing bladder reconstruction.
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Table 2
Results from Multivariable Logistic Regression Analysis Predicting Odds of Any Bladder Reconstruction 
Surgery, National Spina Bifida Patient Registry (NSBPR), 2009–2014
Variables Adjusted Odds Ratio* (95% CI) P-value
Age group at annual visit
 Younger than 2 Reference
 2 to <5 1.97 (0.90 – 4.34)
 5 to <10 8.94 (4.47 – 17.90)
<0.001
 10 to <13 17.16 (8.51 – 34.58)
 13 to <18 28.71 (14.48 – 56.91)
 18 to <22 27.56 (13.79 – 55.08)
 22 or older 23.62 (11.80 – 47.30)
Sex
 Male Reference <0.001
 Female 1.33 (1.15 – 1.54)
Race/Ethnicity
 Non-Hispanic White Reference
 Non-Hispanic Black 0.76 (0.56 – 1.03) 0.19
 Hispanic or Latino 0.99 (0.79 – 1.25)
 Other 0.76 (0.55 – 1.07)
Insurance
 Any private Reference 0.11
 Non-private 1.13 (0.97 – 1.32)
Spina bifida type
 Myelomeningocele Reference <0.001
 Non-Myelomeningocele 0.47 (0.37 – 0.60)
Mobility status
 Community Ambulators Reference
 Household Ambulators 1.30 (0.98 – 1.72) <0.001
 Non-Functional Ambulators 1.69 (1.29 – 2.22)
 Non-Ambulators 1.71 (1.44 – 2.02)
Center
 1 Reference
 2 1.44 (0.82 – 2.50)
 3 0.74 (0.39 – 1.41)
 4 1.32 (0.88 – 1.97)
 5 0.90 (0.62 – 1.31)
 6 0.90 (0.60 – 1.35)
 7 1.96 (1.38 – 2.79)
 8 3.85 (2.72 – 5.45)
 9 1.10 (0.71 – 1.72)
<0.001
 10 0.70 (0.46 – 1.06)
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Variables Adjusted Odds Ratio* (95% CI) P-value
 11 1.13 (0.79 – 1.61)
 12 0.99 (0.69 – 1.43)
 13 0.76 (0.54 – 1.07)
 14 0.93 (0.64 – 1.35)
 15 0.56 (0.34 – 0.95)
 16 1.79 (1.28 – 2.50)
 17 0.88 (0.45 – 1.71)
 18 1.42 (0.98 – 2.06)
 19 1.32 (0.69 – 2.53)
*All listed variables included in the final model
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